Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cardiac transplantation.

H A Valantine1, J S Schroeder

  • 1Department of Medicine, Stanford University School of Medicine, CA.

Intensive Care Medicine
|January 1, 1989
PubMed
Summary
This summary is machine-generated.

Cardiac transplantation offers a viable treatment for end-stage heart failure, but faces challenges in monitoring immunosuppression and preventing accelerated coronary disease. Ongoing research seeks non-invasive methods for rejection surveillance and improved long-term graft survival.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transdisciplinary translational science and the case of preterm birth.

Journal of perinatology : official journal of the California Perinatal Association·2012
Same author

Outcome in cardiac recipients of donor hearts with increased left ventricular wall thickness.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2007
Same author

Wound healing complications with de novo sirolimus versus mycophenolate mofetil-based regimen in cardiac transplant recipients.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2006
Same author

Mycophenolate mofetil reduces intimal thickness by intravascular ultrasound after heart transplant: reanalysis of the multicenter trial.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2006
Same author

Conversion of cyclosporine to tacrolimus for refractory or persistent myocardial rejection.

Transplantation proceedings·2002
Same author

Coronary heart disease in African Americans.

Heart disease (Hagerstown, Md.)·2002
Same journal

Publisher Correction: Current knowledge and challenges of sepsis-associated encephalopathy.

Intensive care medicine·2026
Same journal

Prehospital airway and ventilatory management: a collaborative and narrative review.

Intensive care medicine·2026
Same journal

Rapid coma with bilateral basal ganglia involvement.

Intensive care medicine·2026
Same journal

From size to function: moving beyond body mass index to frailty and central adiposity phenotypes.

Intensive care medicine·2026
Same journal

Effects of a clinical metagenomics intervention on clinical outcomes, healthcare costs, and health-related quality of life in patients with sepsis or septic shock: results of the randomized-controlled DigiSep trial.

Intensive care medicine·2026
Same journal

Hypercalcemia in intensive care unit: pathophysiological mechanisms and clinical implications.

Intensive care medicine·2026
See all related articles

Area of Science:

  • Cardiology
  • Transplantation Medicine
  • Immunology

Background:

  • Cardiac transplantation is an established therapy for end-stage myocardial failure.
  • Survival rates at 1 and 5 years are 85% and 65% with appropriate donor-recipient matching.
  • Key challenges include managing immunosuppression and combating accelerated coronary disease.

Purpose of the Study:

  • To review the current status of cardiac transplantation.
  • To highlight the primary challenges in post-transplant management.
  • To discuss strategies for immunosuppression and surveillance.

Main Methods:

  • Review of current clinical practices in cardiac transplantation.
  • Discussion of immunosuppressive regimens, including OKT3, corticosteroids, cyclosporine, and azathioprine.

Related Experiment Videos

  • Evaluation of diagnostic methods for rejection and coronary disease.

    • Main Results:

    • Endomyocardial biopsy is the gold standard for rejection surveillance, but non-invasive methods are under investigation.
    • Combination immunosuppression therapy aims to minimize side effects.
    • Common complications include infections, nephrotoxicity, and malignancy.
    • Accelerated coronary disease is a major limitation to long-term survival, diagnosed via coronary arteriography.

    Conclusions:

    • Cardiac transplantation is effective but requires careful management of immunosuppression and vigilance for complications.
    • Accelerated coronary disease remains a critical barrier to long-term success, necessitating retransplantation.
    • Further research into non-invasive surveillance and prevention of graft vasculopathy is crucial.